Loss of lrig1 leads to expansion of brunner glands followed by duodenal adenomas with gastric metaplasia

American Journal of Pathology

Volumn 185, Issue 4, 2015, Pages 1123-1134

  Wang, Yang ^a   Shi, Chanjuan ^a   Lu, Yuanyuan ^a   Poulin, Emily J ^b   Franklin, Jeffery L ^b   Coffey, Robert J ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; BETACELLULIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GROWTH FACTOR RECEPTOR; LEUCINE RICH REPEATS AND IMMUNOGLOBULIN LIKE DOMAINS 1; MUCIN 6; UNCLASSIFIED DRUG; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; LRIG1 PROTEIN, HUMAN; LRIG1 PROTEIN, MOUSE; MEMBRANE PROTEIN; NERVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUNNER GLAND; CANCER GRADING; COHORT ANALYSIS; CONTROLLED STUDY; DUODENAL ADENOMA; DUODENUM CARCINOMA; DUODENUM TUMOR; GASTRIC METAPLASIA; HISTOPATHOLOGY; IMMUNOREACTIVITY; METAPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; STOMACH DISEASE; UPREGULATION; ADENOMA; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL PROLIFERATION; DEFICIENCY; HUMAN; METABOLISM; PATHOLOGY; STOMACH;

ADENOMA; ANIMALS; BRUNNER GLANDS; CELL PROLIFERATION; DUODENAL NEOPLASMS; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; METAPLASIA; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; STOMACH;

EID: 84925332305     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.12.014     Document Type: Article

References (38)

1. M.A. Lemmon, and J. Schlessinger Cell signaling by receptor tyrosine kinases Cell 141 2010 1117 1134
2. N.E. Hynes, and G. MacDonald ErbB receptors and signaling pathways in cancer Curr Opin Cell Biol 21 2009 177 184
3. W.H. Fiske, D. Threadgill, and R.J. Coffey ERBBs in the gastrointestinal tract: recent progress and new perspectives Exp Cell Res 315 2009 583 601
4. B. Singh, G. Bogatcheva, M.K. Washington, and R.J. Coffey Transformation of polarized epithelial cells by apical mistrafficking of epiregulin Proc Natl Acad Sci U S A 110 2013 8960 8965
5. J.A. Barnard, R. Graves-Deal, M.R. Pittelkow, R. DuBois, P. Cook, G.W. Ramsey, P.R. Bishop, L. Damstrup, and R.J. Coffey Auto-and cross-induction within the mammalian epidermal growth factor-related peptide family J Biol Chem 269 1994 22817 22822
6. R.J. Coffey Jr., R. Derynck, J.N. Wilcox, T.S. Bringman, A.S. Goustin, H.L. Moses, and M.R. Pittelkow Production and auto-induction of transforming growth factor-alpha in human keratinocytes Nature 328 1987 817 820
7. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
8. N. Gotoh Feedback inhibitors of the epidermal growth factor receptor signaling pathways Int J Biochem Cell Biol 41 2009 511 515
9. Y. Wang, E.J. Poulin, and R.J. Coffey LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor Br J Cancer 108 2013 1765 1770
10. G. Gur, C. Rubin, M. Katz, I. Amit, A. Citri, J. Nilsson, N. Amariglio, R. Henriksson, G. Rechavi, H. Hedman, R. Wides, and Y. Yarden LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation EMBO J 23 2004 3270 3281
11. P.A. Thompson, I. Ljuslinder, S. Tsavachidis, A. Brewster, A. Sahin, H. Hedman, R. Henriksson, M.L. Bondy, and B.S. Melin Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer Cancer Res 74 2014 2928 2935
12. J.K. Miller, D.L. Shattuck, E.Q. Ingalla, L. Yen, A.D. Borowsky, L.J. Young, R.D. Cardiff, K.L. Carraway III, and C. Sweeney Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer Cancer Res 68 2008 8286 8294
13. A.K. Lindstrom, K. Ekman, U. Stendahl, T. Tot, R. Henriksson, H. Hedman, and D. Hellberg LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking Int J Gynecol Cancer 18 2008 312 317
14. A. Tanemura, T. Nagasawa, S. Inui, and S. Itami LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases Dermatol Surg 31 2005 423 430
15. D. Lindquist, S. Kvarnbrink, R. Henriksson, and H. Hedman LRIG and cancer prognosis Acta Oncol 53 2014 1135 1142
16. M. Johansson, A. Oudin, K. Tiemann, A. Bernard, A. Golebiewska, O. Keunen, F. Fack, D. Stieber, B. Wang, H. Hedman, and S.P. Niclou The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status Neuro Oncol 15 2013 1200 1211
17. X.C. Qi, D.J. Xie, Q.F. Yan, Y.R. Wang, Y.X. Zhu, C. Qian, and S.X. Yang LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2 Biochem Biophys Res Commun 437 2013 565 572
18. A.E. Powell, Y. Wang, Y. Li, E.J. Poulin, A.L. Means, M.K. Washington, J.N. Higginbotham, A. Juchheim, N. Prasad, S.E. Levy, Y. Guo, Y. Shyr, B.J. Aronow, K.M. Haigis, J.L. Franklin, and R.J. Coffey The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor Cell 149 2012 146 158
19. R. Edgar, M. Domrachev, and A.E. Lash Gene Expression Omnibus: NCBI gene expression and hybridization array data repository Nucleic Acids Res 30 2002 207 210
20. W.J. Krause Brunner's glands: a structural, histochemical and pathological profile Prog Histochem Cytochem 35 2000 259 367
21. S.S. Poulsen, E. Nexo, P.S. Olsen, J. Hess, and P. Kirkegaard Immunohistochemical localization of epidermal growth factor in rat and man Histochemistry 85 1986 389 394
22. P. Kirkegaard, P.S. Olsen, S.S. Poulsen, and E. Nexo Exocrine secretion of epidermal growth factor from Brunner's glands. Stimulation by VIP and acetylcholine Regul Pept 7 1983 367 372
23. K. Hormi, J.P. Onolfo, L. Gres, V. Lebraud, and T. Lehy Developmental expression of transforming growth factor-alpha in the upper digestive tract and pancreas of the rat Regul Pept 55 1995 67 77
24. N. Shepherd, N. Carr, J. Howe, A. Noffsinger, and B. Warren Tumors of the small intestine F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise, WHO Classification of Tumours of the Digestive System, ed 4 2010 International Agency for Research on Cancer Lyon 98 101
25. D.J. Ahnen, R. Poulsom, G.W. Stamp, G. Elia, C. Pike, R. Jeffery, J. Longcroft, M.C. Rio, P. Chambon, and N.A. Wright The ulceration-associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland J Pathol 173 1994 317 326
26. R. Shaoul, P. Marcon, Y. Okada, E. Cutz, and G. Forstner The pathogenesis of duodenal gastric metaplasia: the role of local goblet cell transformation Gut 46 2000 632 638
27. R. Kushima, R. Manabe, T. Hattori, and F. Borchard Histogenesis of gastric foveolar metaplasia following duodenal ulcer: a definite reparative lineage of Brunner's gland Histopathology 35 1999 38 43
28. S.M. Gormally, B.M. Kierce, L.E. Daly, B. Bourke, R. Carroll, M.T. Durnin, and B. Drumm Gastric metaplasia and duodenal ulcer disease in children infected by Helicobacter pylori Gut 38 1996 513 517
29. S. Shousha, R.A. Parkins, and T.B. Bull Chronic duodenitis with gastric metaplasia: electron microscopic study including comparison with normal Histopathology 7 1983 873 885
30. R. Kushima, M. Stolte, K. Dirks, M. Vieth, H. Okabe, F. Borchard, and T. Hattori Gastric-type adenocarcinoma of the duodenal second portion histogenetically associated with hyperplasia and gastric-foveolar metaplasia of Brunner's glands Virchows Arch 440 2002 655 659
31. A.S. Tarnawski, and A. Ahluwalia Molecular mechanisms of epithelial regeneration and neovascularization during healing of gastric and esophageal ulcers Curr Med Chem 19 2012 16 27
32. A. Sinha, J. Nightingale, K.P. West, J. Berlanga-Acosta, and R.J. Playford Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis N Engl J Med 349 2003 350 357
33. F. Ledda, O. Bieraugel, S.S. Fard, M. Vilar, and G. Paratcha Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF J Neurosci 28 2008 39 49
34. D.L. Shattuck, J.K. Miller, M. Laederich, M. Funes, H. Petersen, K.L. Carraway III, and C. Sweeney LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy Mol Cell Biol 27 2007 1934 1946
35. M.B. Laederich, M. Funes-Duran, L. Yen, E. Ingalla, X. Wu, K.L. Carraway III, and C. Sweeney The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases J Biol Chem 279 2004 47050 47056
36. Y. Ohta, K. Saitoh, T. Akai, M. Uesato, T. Ochiai, and H. Matsubara Early primary duodenal carcinoma arising from Brunner's glands synchronously occurring with sigmoid colon carcinoma: report of a case Surg Today 38 2008 756 760
37. K. Kawamoto, M. Motooka, N. Hirata, K. Masuda, T. Ueyama, A. Yasukouchi, A. Iwashita, K. Matsuzawa, and T. Katsuyama Early primary carcinoma of the duodenal bulb arising from Brunner's glands Gastrointest Endosc 40 1994 233 236
38. K. Kitagori, S. Miyamoto, and T. Sakurai Image of the month. Adenocarcinoma derived from Brunner's gland Clin Gastroenterol Hepatol 8 2010 A26